Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0018799 (
heart disease
)
34,133
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Obesity is an important risk factor for
heart disease
, diabetes, and certain cancers, but the molecular basis for obesity is poorly understood. The transcriptional repressor
AEBP1
, which functions as a negative regulator of PTEN through a protein-protein interaction, is highly expressed in the stromal compartment of adipose tissues, including proliferative preadipocytes, and its expression is abolished in terminally differentiated, nonproliferative adipocytes. Here we show that transgenic overexpression of
AEBP1
during adipogenesis coupled with a high-fat diet (HFD) resulted in massive obesity in female transgenic (
AEBP1
(TG)) mice via adipocyte hyperplasia.
AEBP1
levels dynamically changed with aging, and HFD induced
AEBP1
expression in females. Thus, HFD-fed
AEBP1
(TG) females display hyperinduction of
AEBP1
and a marked reduction of PTEN level with concomitant hyperactivation of the survival signal in white adipose tissue. Our results suggest that
AEBP1
plays a key functional role in in vivo modulation of adiposity via fat-cell proliferation and is involved in a sex-specific susceptibility to diet-induced obesity by the estrogen signaling pathway.
...
PMID:The role of AEBP1 in sex-specific diet-induced obesity. 1630 71